Skip to main navigation
Skip to main content
Skip to Footer
UK
Novartis Site Directory
Our Work
Clinical Trials
Disease Areas
Novartis in the UK
Partnerships
Sponsorships
External Funding
For UK Healthcare Professionals
About Us
Who We Are
Patient group partnership
Corporate Responsibility
Patients & Caregivers
Contact Us
News
UK News Archive
Stories
Novartis UK Press Office
Careers
Our People and Culture
Future Talent Programme
Career Search
Search
UK News Archive
The UK News Archive contains resources intended for journalists only.
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Media Releases
Stories
Filter By
2022
January
Media Release
/
Jan 24, 2022
People with chronic myeloid leukaemia granted early access to Novartis’ investigational treatment
Read More
Media Release
/
Jan 19, 2022
Roland Kreissig appointed Oncology General Manager, Novartis UK and Ireland
Read More
2021
December
Media Release
/
Dec 23, 2021
MHRA approves licence extension for Novartis’ targeted therapy for advanced breast cancer patients in Great Britain
Read More
October
Media Release
/
Oct 28, 2021
Connecting Psoriasis and Psoriatic Arthritis - raising awareness of psoriatic disease
Read More
Media Release
/
Oct 28, 2021
Novartis Pharmaceuticals UK awarded an Innovation Passport for investigational oral therapy iptacopan (LNP023)
Read More
Media Release
/
Oct 19, 2021
Novartis awarded Promising Innovative Medicine designation for targeted radioligand theragnostics in prostate cancer
Read More
Media Release
/
Oct 05, 2021
The first treatment for sickle cell disease in over 20 years, Novartis’ Adakveo®▼ (crizanlizumab) receives NICE recommendation for preventing recurrent vaso-occlusive crises
Read More
September
Media Release
/
Sep 20, 2021
Novartis unveils new data at ESMO 2021, including compelling longest ever reported median overall survival data in advanced breast cancer, as it continues to push the boundaries of innovation
Read More
Media Release
/
Sep 06, 2021
NICE recommends Novartis Cosentyx® (secukinumab) for children and young people with moderate to severe psoriasis
Read More
Media Release
/
Sep 01, 2021
World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio®▼ (inclisiran) across England
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
Page
1
of 3
Current page
2
of 3
Page
3
of 3
Next page
next ›
Last page
last »
Related Links
News
You are here
Home
›
News